Opko Health (Israel) Top Management

OPK Stock   547.10  46.90  7.90%   
Opko Health employs about 5.8 K people. The company is managed by 9 executives with a total tenure of roughly 34 years, averaging almost 3.0 years of service per executive, having 640.78 employees per reported executive. Analysis of Opko Health's management performance can provide insight into the company performance.
Phillip Frost  Chairman
Chairman of the Board, CEO
Akhtar Ashfaq  President
Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Opko Stock refer to our How to Trade Opko Stock guide.

Opko Health Management Team Effectiveness

The company has return on total asset (ROA) of (0.0659) % which means that it has lost $0.0659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1867) %, meaning that it generated substantial loss on money invested by shareholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities.

Opko Health Workforce Comparison

Opko Health is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is now estimated at about 65,042. Opko Health holds roughly 5,767 in number of employees claiming about 9% of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of (0.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.2.

Opko Health Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Opko Health Price Series Summation is a cross summation of Opko Health price series and its benchmark/peer.

Opko Health Notable Stakeholders

An Opko Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Opko Health often face trade-offs trying to please all of them. Opko Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Opko Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Phillip FrostChairman of the Board, CEOProfile
Akhtar AshfaqSenior Vice President - Clinical Research and Development of OPKO Health's Renal DivisionProfile
Adam LogalCFO, Chief Accounting Officer, Sr. VP and TreasurerProfile
Arie GutmanPres APIProfile
James DeMarcoVP SalesProfile
Elias MDPres ChairmanProfile
JD EsqChief LaboratoriesProfile
MBA MBAVice OfficerProfile
Jon MDAdvisorProfile

About Opko Health Management Performance

The success or failure of an entity such as Opko Health often depends on how effective the management is. Opko Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Opko management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Opko management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. OPKO HEALTH operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 5690 people.
Please note, the presentation of Opko Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Opko Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Opko Health's management manipulating its earnings.

Opko Health Workforce Analysis

Traditionally, organizations such as Opko Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Opko Health within its industry.

Opko Health Manpower Efficiency

Return on Opko Health Manpower

Revenue Per Employee307.7K
Revenue Per Executive197.2M
Net Loss Per Employee5.2K
Net Loss Per Executive3.3M

Complementary Tools for Opko Stock analysis

When running Opko Health's price analysis, check to measure Opko Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opko Health is operating at the current time. Most of Opko Health's value examination focuses on studying past and present price action to predict the probability of Opko Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opko Health's price. Additionally, you may evaluate how the addition of Opko Health to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets